Status:
COMPLETED
Trial of Valproic Acid in Patients With Progressive Supranuclear Palsy (Depakine)
Lead Sponsor:
Nantes University Hospital
Conditions:
Progressive Supranuclear Palsy
Eligibility:
All Genders
45-75 years
Phase:
PHASE2
Brief Summary
Progressive Supranuclear Palsy (PSP) is a relentlessly progressive neurodegenerative disorder, clinically characterized by parkinsonism with prominent axial involvement and postural instability, bulba...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients with possible or probable PSP
- from 45 to 75 year of age
Exclusion
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2010
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT00385710
Start Date
November 1 2006
End Date
July 1 2010
Last Update
November 5 2012
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Neurologie A, Hôpital Gabriel Montpied-BP
Clermont-Ferrand, France, 63009
2
Service de Neurologie et Pathologie du mouvement Hôpital Roger Salingro, CHRU de Lille
Lille, France, 59000
3
Service de Neurologie, CHU Nantes
Nantes, France, 44093
4
Service de Neurologie, CHU Poitiers
Poitiers, France, 86021